A mother in Israel’s Northern District told researchers what she remembered about her child’s vaccination visit, and it wasn’t the needle. The nurse, she said, “put me under a lot of stress and made me feel guilty and remorseful.” The offense, as the clinic saw it, was wanting the combination shot broken into separate injections, a choice Israel’s public-health system now treats as a problem worth a half-million-child study.

That study, published this year in Vaccines, set out to measure what splitting costs. It found that 75.1 percent of children who got a single-antigen measles shot in place of MMRV, the combined measles, mumps, rubella and varicella vaccine given at 12 months, were vaccinated late. According to the paper’s full text, 63.4 percent of the children who received MMRV, the shot the ministry recommends, were late too. The guilt in that clinic was aimed at a gap of about 12 percentage points, laid on top of a system that missed its own deadline for nearly two of every three children who got the recommended vaccine.

Half a million children, and a sliver of dissenters

Efrat Sales of Ben-Gurion University and five co-authors drew on Ministry of Health records for 499,975 children born in Israel from 2018 to 2021, each of whom attended at least one visit at the 498 Maternal and Child Health clinics in the sample. That covers 68.6 percent of the 728,733 children born in those years. The team then interviewed 20 clinic nurses, 10 policymakers and 20 parents.

The dissenters are few. Only 4,319 children, 0.9 percent, received any split vaccine. Of those, 2,933, or 0.59 percent of the cohort, got single-antigen measles in place of MMRV, and 686 got single-antigen pertussis in place of the five-in-one pentavalent shot. A dose counted as late if it arrived more than five weeks after its target age, and the authors report that the pattern held at four- and eight-week cutoffs.

On pertussis the split group fared badly: 65.9 percent of children on the split first dose were late, against 13.9 percent on the combination shot, and the paper reports that most children who skipped the combination did not complete the schedule in the records it analyzed. The measles comparison is a different animal. A 75.1 percent late rate for splitters sits beside a 63.4 percent late rate for everyone else, and the paper, which counts the splitters carefully, never explains the second number. Its Discussion speaks of delay in general terms and does not take up the 63.4 percent at all. A study built to document parental deviation ends up documenting that in the ministry’s own clinics the standard measles shot usually arrives late.

LATE DOSES, SPLIT VS COMBINATION
LATE DOSES, SPLIT VS COMBINATION
DoseSplit shot (% late)Combination shot (% late)
Pertussis, first dose65.913.9
Measles75.163.4
Share of children vaccinated more than five weeks after the target age, in clinic records for children born from 2018 to 2021. Source: the paper's full text

The authors’ framing of why parents split is also more confident than their evidence. The abstract describes parental concerns as “often amplified by misinformation,” and one results section runs under the heading “Misinformation and Social Media Influence.” Yet the CDC’s own vaccine-safety page on MMRV states that in children 12 to 23 months old, a federal safety study found 1 additional febrile seizure for every 2,300 first doses of MMRV compared with separate MMR and varicella shots, and it tells providers who use the combination to “clearly communicate to parents and caregivers the increased risk of fever and seizure.” Israel gives that first MMRV dose at 12 months. The paper does not record which families had that signal in mind, but a parent asking to break up this particular combination is asking about a risk the American agency itself puts in writing.

A ministry grading its own clinics

One co-author, Deena Zimmerman, is listed in the paper’s full text with the Ministry of Health’s Maternal Child and Adolescent Department in Jerusalem. The authors report no external funding and declare no conflicts of interest. It still means the ministry’s maternal and child health department sits among the people assessing how the ministry’s maternal and child health clinics perform, and the verdict lands mostly on parents.

The paper’s own interviews point somewhere else. Its results report that trust in the Ministry of Health declined during and after the acute phase of COVID-19, as parents questioned frequent guideline changes. “I don’t have much trust anymore,” a Central District parent said. Nobody needed TikTok to produce that sentence; the ministry’s own record of shifting pandemic guidance did the work, and the people it lost were the ones still bringing their children to its clinics. The paper’s language for friction inside those clinics is “communication challenges and systemic constraints in busy clinic settings,” a gentle phrase for what the Northern District mother described.

The clinic staff, for their part, sounded more practical than the paper’s framing. “We don’t argue with parents,” a Jerusalem nurse said. A policymaker put the case for accepting split schedules plainly: “it’s better than not vaccinating at all.”

Where the children died

All of this now sits beside a lethal outbreak. By July 2026, Haaretz reported more than 3,700 diagnosed cases nationwide, 1,226 hospitalizations and 17 deaths among infants and children.

Eleven of those deaths were in Jerusalem between April 2025 and March 2026, according to a Ministry of Health report in Emerging Infectious Diseases. Ten of the children were otherwise healthy. Nine of them were under 3, had received no vaccinations, and were not registered with a mother-and-child health clinic; the report does not give the tenth healthy child’s age or history. The eleventh was a 7-year-old with truncus arteriosus, a congenital heart defect, who received one MMRV dose at age 1 and never got the second. None of the children whose histories the report gives was on a split schedule. The split-schedule families showed up at the clinic. Nine of the dead children never did.

The same report shows how far the clinics’ reach had fallen before the outbreak began. MMR and MMRV uptake among Jerusalem children aged 1 to 6 fell from 94.7 percent in 2019 to 78.3 percent in 2024, the lowest in Israel. In six central neighborhoods, first-dose coverage was about 55.0 percent in April 2025, and those neighborhoods accounted for 68.7 percent of the city’s 1,289 cases. The Sales cohort, by design, includes only children who attended at least one clinic visit, and its authors acknowledge that the missing families are unlikely to be random. The nine unregistered children in the death report are, by definition, the kind of children it could not count.

The schedule moves when the ministry needs it to

On July 1, the ministry changed the schedule again. For children born on or after January 1, 2025, the second MMRV dose moves from age six to 18 months, with both doses given at well-baby clinics; in areas designated as outbreak hotspots, an MMRV dose is also given at six months. Siegal Sadetzki, head of the ministry’s Public Health Services, called the change “an important step.” Pulling the second dose earlier during an outbreak is a defensible call.

It is also one more revision of guidance from a ministry whose own department co-authored a paper recording that frequent guideline changes cost it parents’ trust. The authors recommend “empathetic yet consistent communication.” The ministry now holds a dataset from its own clinics showing its recommended measles shot arrived late for 63.4 percent of the children who received it, and a death report in which nine of the children it describes had never been registered at a clinic at all. Its prescription, on the page, is a better tone with the parents who kept coming in.

Sources

  1. Vaccines (2026): Sales, Cohen, Zimmerman, Davidovitch, McCallum, Dopelt, “Alternative Childhood Vaccination Schedules in Israel: A Mixed-Methods Study on Prevalence, Patterns, and Public Health Implications”
  2. Full text of the Sales et al. study, PubMed Central
  3. Emerging Infectious Diseases: Pediatric Deaths during Measles Outbreak, Jerusalem, Israel, 2025–2026
  4. Haaretz: Second Measles Vaccine Dose Moved From Age Six to 18 Months, Says Health Ministry (July 1, 2026)
  5. CDC: Measles, Mumps, Rubella and Varicella (MMRV) Vaccine Safety